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Evaluation of Polymorphic Locus Sequence Typing for Candida
glabrata Epidemiology
Santosh Katiyar,a Eric Shiffrin,a* Celeste Shelton,a* Kelley Healey,a* John-Paul Vermitsky,a* Tom Edlindb
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USAa; MicrobiType LLC, Plymouth Meeting,
Pennsylvania, USAb
The opportunistic yeast Candida glabrata is increasingly refractory to antifungal treatment or prophylaxis and relatedly is in-
creasingly implicated in health care-associated infections. To elucidate the epidemiology of these infections, strain typing is re-
quired. Sequence-based typing provides multiple advantages over length-based methods, such as pulsed-field gel electrophoresis
(PFGE); however, conventional multilocus sequence typing (targeting 6 conserved loci) and whole-genome sequencing are im-
practical for routine use. A commercial sequence-based typing service for C. glabrata that targets polymorphic tandem repeat-
containing loci has recently been developed. These CgMT-J and CgMT-M services were evaluated with 56 epidemiologically un-
related isolates, 4 to 7 fluconazole-susceptible or fluconazole-resistant isolates from each of 5 center A patients, 5 matched pairs
of fluconazole-susceptible/resistant isolates from center B patients, and 7 isolates from a center C patient who responded to then
failed caspofungin therapy. CgMT-J and CgMT-M generated congruent results, resolving isolates into 24 and 20 alleles, respec-
tively. Isolates from all but one of the center A patients shared the same otherwise rare alleles, suggesting nosocomial transmis-
sion. Unexpectedly, Pdr1 sequencing showed that resistance arose independently in each patient. Similarly, most isolates from
center B also clustered together; however, this may reflect a dominant clone since their alleles were shared by multiple unrelated
isolates. Although distinguishable by their echinocandin susceptibilities, all isolates from the center C patient shared alleles, in
agreement with the previously reported relatedness of these isolates based on PFGE. Finally, we show how phylogenetic clusters
can be used to provide surrogate parents to analyze the mutational basis for antifungal resistance.
Candida species are among the most common agents of healthcare-associated infections and, in particular, nosocomial
bloodstream infections (1–8). At highest risk are those aged 65
and older, which is consistent with their increased likelihood of
being diabetic, in the ICU, or on immunosuppressive or pro-
longed antibiotic therapies, all major risk factors for invasive yeast
infection (4, 5). The species responsible for roughly half of these
infections is Candida albicans, for which the source is predomi-
nantly endogenous, as evidenced by comparing genotypes of in-
vasive isolates with those from mucosal isolates obtained before
invasive infection (9–11). Endogenous transmission is consistent
with the fact that C. albicans colonizes the mucosal epithelium in
up to 70% of humans, which is mediated by multiple adherence
mechanisms, yeast-hyphae dimorphism, secretion of hydrolytic
enzymes, and biofilm formation (12).
These colonization factors are relatively deficient or absent in
Candida glabrata, the second most likely cause of invasive yeast
infection (4, 5, 13). However, C. glabrata exhibits intrinsically low
susceptibility to azole antifungals and readily develops full resis-
tance to these agents due to mutations in transcription factor Pdr1
(14–17). Since azoles such as fluconazole are widely used for pro-
phylaxis or empirical therapy in high-risk patients (18), this could
drive nosocomial transmission. Indeed, nosocomial transmission
of C. glabrata has been repeatedly documented, although with
various degrees of confidence (4, 11, 19–27). To make this con-
nection, a strain-typing system is required that combines high
resolution (diversity index of 0.9, where 1.0 represents 100%
resolution) with reproducibility (facilitating comparisons over
periods of months or longer) and, ideally, portability (facilitating
comparisons to other labs and to strain databases).
Multiple approaches have been developed to type C. glabrata
isolates (28). The most widely applied include (i) multilocus se-
quence typing (MLST), which analyzes 6 relatively conserved
housekeeping loci for single nucleotide polymorphisms (SNPs)
(29, 30), (ii) pulsed-field gel electrophoresis (PFGE), which com-
pares total DNA banding patterns with or without restriction
enzyme digestion (14, 23, 31), (iii) multilocus variable-number
tandem-repeat analysis (MLVA, also known as microsatellite
analysis), which examines length variation in 6 to 9 PCR-ampli-
fied loci that contain polymorphic tandem repeats (32–35), and
(iv) random amplification of polymorphic DNA (RAPD), which
compares banding patterns following PCR with a nonspecific
primer (26, 36). In general, these methods are comparable in their
strain resolution, achieving diversity indexes of ca. 0.9. However,
these four approaches are also characterized by shared or unique
limitations. First, most require facilities and expertise not gener-
ally available to clinical laboratories. Second, with the exception of
MLST, which is sequence-based, the typing data are length-based,
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which has inherently lower reproducibility and portability. Third,
these methods can be expensive, particularly MLST, due to the
requirement for 6 sets of sequencing reactions. Finally, turn-
around time can be slow, precluding real-time use for outbreak
detection and investigation.
Here, we evaluate an approach to C. glabrata strain typing that
directly addresses these limitations. This approach employs se-
quence-based typing and hence shares the high reproducibility
and portability of MLST but targets tandem-repeat-containing
loci rather than housekeeping loci. The inherently higher poly-
morphism of tandem repeats (due to DNA slippage during repli-
cation) is also exploited by MLVA, but sequencing can be consid-
erably more informative than length analysis alone due to the
complex patterns of insertions or deletions (indels) as well as
SNPs. Thus, epidemiologically useful strain resolution can be
achieved with a single sequencing reaction, reducing cost, com-
plexity, and turnaround time. Furthermore, this approach can be
outsourced to a commercial typing service, which eliminates the
need for in-house facilities and expertise. Polymorphic locus se-
quence typing (PLST) is well established for bacterial pathogens,
including Staphylococcus aureus (spa typing) and Streptococcus
pyogenes (emm typing), and was recently introduced for Listeria
monocytogenes (37–39). With respect to fungi, the polymorphic
tandem repeat CSP has similarly been exploited to type isolates of
Aspergillus fumigatus, a haploid mold (40, 41). Although PLST is
largely precluded in C. albicans and related yeast due to their dip-
loid, frequently heterozygous genomes (our unpublished data),
we show here that it is well suited for typing haploid C. glabrata.
MATERIALS AND METHODS
Strains and culture. The strains used in this study and their sources are
listed in Table 1. From frozen glycerol stocks, strains were streaked for
isolation on yeast extract-peptone-dextrose (YPD) (1% yeast extract, 2%
peptone, 2% dextrose) agar plates, with incubation at 35°C for 48 h. Flu-
conazole susceptibility or resistance (MIC of 32 g/ml or 64 g/ml,
respectively) and the CRS-MIS phenotype (4-fold caspofungin reduced
susceptibility and micafungin increased susceptibility) were determined
by broth microdilution as previously described (15, 42).
Template preparation. To prepare lysates, single isolated colonies
were suspended in 0.3 ml Tris-EDTA (TE) (10 mM Tris, 1 mM EDTA, pH
7.5) buffer in 1.5-ml tubes containing an equal volume of 0.5-mm glass
beads. Tubes were vigorously shaken for 10 min, heated to 100°C for 10
min, and centrifuged 5 min to pellet beads and debris. To purify DNA,
lysates were extracted with an equal volume of phenol-chloroform (24:1),
and the aqueous layer was subjected to ethanol precipitation twice with
final resuspension in 50 l TE.
Amplification and sequencing. For typing, purified DNAs or lysates
were transported to MicrobiType (Plymouth Meeting, PA) at ambient
temperature. Tubes were briefly centrifuged, and 0.5-l aliquots were
used as the template in 15-l PCR mixtures with Taq polymerase as rec-
ommended by the manufacturer (New England BioLabs, Ipswich, MA),
for 30 (purified DNA) or 32 (lysate) cycles. Products (4l) were analyzed
by 1% agarose gel electrophoresis and were visualized with blue light
illumination after staining with SYBR Safe (Invitrogen, Grand Island,
NY). For sequencing, products (1.5 l) were treated with ExoSAP-IT as
recommended by the manufacturer (Affymetrix, Santa Clara, CA),
primer was added to 2 M, and samples were submitted to Genewiz
(South Plainfield, NJ). For CgMT-J and CgMT-M, amplification and se-
quencing primers (proprietary sequences; synthesized by IDT, Coralville,
IA) were subjected to extensive laboratory testing to maximize sensitivity
and specificity. For C. glabrata MLST, the primers described by Dodgson
et al. (29) were used with minor modifications.
To identify Pdr1 substitutions in fluconazole-resistant KM isolates,
lysates (1 l) were used as the templates as described above but in 50-l
PCR mixtures. Primers were CgPDR1uF (5=-CTTCCATTACTTCGTAC
CCCA) and CgPDRc555R (5=-CGTCGAGAGCAAGCTGTTCT) for am-
plification of the N-terminal coding region and CgPDR1c432F (5=-AGA
GAGAATACCGCAACCGTT) and CgPDR1dR (5=-ATACAGGCTATGC
ACACTGTC) for the C-terminal coding region. Following agarose gel
confirmation and ExoSAP-IT treatment, aliquots were sequenced with
the same and additional internal primers to span the full length of
the 3,324-bp coding region. Substitutions relative to strain CBS138 were
identified by BLAST analyses on the CGD website (www.candidagenome
.org) and were confirmed by visual inspection of the sequence chro-
matograms. To characterize the 2,055-bp Ptp2 gene, the procedure above
was modified by the use of primers CgPTP2uF (5=-TGGGATG
CTGGATGTAGTGA) and CgPTP2dR (5=-CATGCTAGCTTTTCGAG
CGA) for amplification and these and additional internal primers for
sequencing. Amplification and sequencing of the Ifa38 gene was as previ-
ously described (42).
Bioinformatics. To identify candidate typing loci within the C.
glabrata CBS138 genome, PatMatch on the CGD website (www
.candidagenome.org) was employed with various simple tandem-repeat
queries. BLASTN searches were conducted on the NCBI website (www
.ncbi.nlm.nih.gov) against the nucleotide (strain CBS138) and whole-ge-
nome shotgun (strain M202019) databases. For phylogenetic analysis,
sequences (edited as needed by visual inspection of chromatograms and
trimmed to common termini) were aligned with Clustal Omega (www.ebi
.ac.uk/Tools/msa/clustalo). Alignments were saved in PHYLIP format,
analyzed using dnapars (PHYLIP version 3.69) with default parameters,
and visualized as dendrograms using drawgram (http://evolution.genetics
.washington.edu/phylip.html). Diversity index (Simpson dominance
index) was calculated (www.alyoung.com/labs/biodiversity_calculator
.html) using the formula D 1 [ n(n 1)/N(N 1)], where n is the
number of strains with a given allele and N is the total number of
TABLE 1 C. glabrata strains used in this study
Strain(s) Source
66032 American Type Culture
Collection (Manassas, VA)
BG2 B. Cormack (Johns Hopkins
University, Baltimore, MD)
20409 D. Diekema and M. Pfaller
(U. Iowa, Iowa City, IA)
0016, 0037, 1437 S. Lockhart (CDC, Atlanta, GA)
34-031-010, 34-016-042, 34-028-512 J. Rex (University of Texas
Health Science Center,
Houston, TX)
CE-03, CE-06, CE-08, CE-14,
CE-16, CE-18
D. Soll (University of Iowa,
Iowa City, IA)
DPL23, DPL34, DPL36, DPL38,
DPL39, DPL41
D. Perlin (University of
Medicine and Dentistry of








S. Gygax (Medical Diagnostic
Laboratories, Hamilton, NJ)
KM1–KM5 series (patients 1–5,
center A)
K. Marr (Fred Hutchinson
Cancer Research Center,
Seattle, WA)





LC-A–LC-G series (single patient,
center C)
L. Cowen (University of
Toronto, Ontario, Canada)
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(epidemiologically unrelated) strains. For MLST, sequences were
trimmed to specified termini, and allele numbers and sequence types
were determined with reference to available databases (http://cglabrata
.mlst.net).
Nucleotide sequence accession numbers. CgMT-J and CgMT-M se-
quences representing each allele identified in this study have been submit-
ted to GenBank with accession numbers KU172441 to KU172461 and
KU172462 to KU172481, respectively.
RESULTS AND DISCUSSION
Identification of candidate loci for C. glabrata PLST. This proj-
ect was initiated when the genome sequence for only one strain,
CBS138, was available (43). PatMatch searches of this sequence
on the CGD website (www.candidagenome.org) identified nu-
merous simple tandem repeats (e.g., poly AC), which were
screened for (i) proximity to other tandem repeats, (ii) location
within an intergenic region, (iii) flanking regions likely to be con-
served, and (iv) a total length of 0.5 to 1 kbp. Candidate loci were
then evaluated by amplification and sequencing from small panels
of unrelated strains, and CgMT-M (on chromosome M, upstream
of CAGL0M00902g) emerged as the most promising. This locus
was independently identified by Grenouillet et al. (35) as one of
the four most informative targets within their MLVA scheme,
which assesses length variation alone. A partial alignment of
CgMT-M sequences from representative strains is shown in Fig.
1A, illustrating polymorphism in the form of indels and SNPs.
More recently, the partial genome sequence for a second C.
glabrata strain, M202019, became available (GenBank accession
number AYJS01000000). This sequence is highly similar to that
for strain CBS138 (e.g., their CgMT-M loci are identical). This
similarity was exploited by searching for rare regions of tandem-
repeat-containing polymorphisms between the two genomes,
which led to the identification of several candidate loci. Again,
these loci were evaluated by amplification and sequencing from
small panels of diverse strains. The most promising, CgMT-J (on
chromosome J), represents the coding region for an uncharacter-
ized protein (CAGL0J02530g) with central and C-terminal repeat
regions; the latter represents the region of polymorphism between
CBS138 and M202019. A partial alignment of CgMT-J sequences
from representative strains is shown in Fig. 1B, illustrating poly-
morphism primarily in the form of indels but also several SNPs.
Phylogenetic analyses of CgMT-J and CgMT-M sequences.
To evaluate CgMT-J and CgMT-M for epidemiological studies,
104 total strains (Table 1) were assembled that include (i) 59 epi-
demiologically unrelated mucosal (primarily vaginal) or blood-
stream isolates, (ii) 27 fluconazole-susceptible or fluconazole-re-
sistant isolates from 5 patients at medical center A, (iii) 11
fluconazole-susceptible or fluconazole-resistant isolates from 6
patients at medical center B, and (iv) 7 sequential isolates exhib-
iting stepwise decreases in caspofungin susceptibility from one
patient at medical center C. All strains yielded sequenceable prod-
FIG 1 Alignment of partial CgMT-M (A) and CgMT-J (B) sequences from representative C. glabrata strains.
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ucts for the two loci, with the exception of the DSY2253-DSY2254
pair from one center B patient, which did not yield a CgMT-J
product despite repeated attempts with different primer combi-
nations. Although most amplifications employed purified DNA
templates, crude lysates (generated by vigorously shaking a colony
suspension with glass beads following by heating to 100°C) also
yielded high-quality sequence chromatograms (not shown).
All CgMT-J and CgMT-M sequences, including those from
strains CBS138 and M202019 downloaded from NCBI databases,
were aligned and phylogenetically analyzed using dnapars
(PHYLIP), which weighs indels and SNPs. From the resulting
dendrograms (Fig. 2 and 3), it is apparent that the two loci yield
largely congruent results. Specifically, the two loci yielded 10 clus-
ters (i.e., sharing identical or nearly identical sequences) of 2 to 21
strains, with equivalent or nearly equivalent sets of strains for
CgMT-J and CgMT-M. For three examples, cluster N (defined by
strain BWN) includes the equivalent set of 21 strains in the two
dendrograms, cluster V (BWV) includes the equivalent set of 11
strains, and cluster J (BWJ) includes the equivalent set of 5 strains.
Note that cluster C, defined by strain CE-14, is unambiguous by
CgMT-M but less so by CgMT-J. With respect to singletons, two
strains (CE-06 and BXG) and one matched pair (DSY738/
DSY739) were identified as such by CgMT-J and CgMT-M (Fig. 2
and 3). In total, CgMT-J and CgMT-M yielded 24 (including the
DSY2253-DSY2254 null) and 20 alleles, respectively. Correspond-
ingly, the diversity indexes (excluding epidemiological replicates;
see below) were 0.94 and 0.91. These values are comparable to
those obtained with other typing methods and strain sets (14, 24,
32, 34, 35).
As expected, resolution was enhanced by combining CgMT-J
and CgMT-M loci, i.e., concatenating their sequences and repeat-
ing the alignment and phylogenetic analysis. Specifically, CgMT-
J/M typing yielded 32 total alleles and a diversity index of 0.95. The
CgMT-J/M dendrogram (not shown) demonstrates equivalent
strain clusters as CgMT-J and CgMT-M (Fig. 2 and 3), which is
consistent with the congruency of the individual loci as noted
above.
Comparison of PLST to MLST and other typing methods.
The 6 CE isolates typed here by PLST were previously typed by
Dodgson et al. (29) using MLST, RAPD, and Southern blot anal-
ysis with repetitive sequence-containing probes Cg6/Cg12. By
PLST, CE-03, CE-16, and CE-18 are indistinguishable (Fig. 2 and
3). Consistent with this, all three were typed to group I by MLST,
RAPD, and Cg6/Cg12, although CE-03 was assigned a distinct
sequence type due to differences in one of the 6 loci (29). Strains
CE-08 and CE-14 are closely related or identical by CgMT-J and
CgMT-M, respectively (Fig. 2 and 3). Similarly, the two strains
typed to group V by MLST (with identical sequence type), RAPD,
and Cg6/Cg12 (29). These three methods also typed CE-06 to
group V; in contrast, it is a singleton by PLST (Fig. 2 and 3).
Since cluster K includes one or both of the C. glabrata strains
(CBS138 and M202019) with sequenced genomes, it was selected
for further comparison of CgMT-J and CgMT-M typing to MLST.
For the remaining 8 strains in this cluster, the 6 MLST loci (29)
were amplified, sequenced, and trimmed to the appropriate ter-
mini. Allele numbers and sequence type were determined with
reference to the C. glabrata MLST database (http://cglabrata.mlst
.net). This analysis revealed that all but one of the 10 cluster K
strains are sequence type 15 (ST15); the exception is strain 34-016-
042, which is ST26. In comparison, cluster K is resolved into 3
types by CgMT-J and CgMT-M (Fig. 2 and 3) and into 4 types by
CgMT-J/M (not shown).
Epidemiological analyses of clinical isolates from medical
centersA,B, andC.As a national referral center for hematopoietic
stem cell transplantation, center A receives patients from geo-
graphically diverse locations. These patients are at high risk for
Candida infection and were routinely prophylaxed or treated with
fluconazole during the period when the isolates tested here were
collected (14). Four of the 5 center A patients—KM1, KM2, KM4,
and KM5—yielded multiple isolates that shared the same CgMT-J
and CgMT-M alleles (Fig. 2 and 3). This was unexpected since
these alleles are otherwise rare, shared by only one noncenter A
strain (BWP, a vaginal isolate from a Michigan patient), which
defines cluster P. Patients KM4 and KM5 were additionally in-
fected with unrelated strains typing to clusters V and S, respec-
tively. Together, these results strongly suggest nosocomial trans-
mission to, or between, these 4 patients. Additionally, their cluster
P isolates were all (KM4 and KM5) or in part (KM1 and KM2)
fluconazole resistant. Thus, it was hypothesized that this transmis-
sion was driven by selection for a fluconazole-resistant clone.
However, analysis of the resistance mechanisms in these strains
demonstrated that this was not the case. Resistance is generally
mediated by mutations in Pdr1, the transcription factor regulating
expression of multidrug transporter genes, particularly CDR1
(15–17). By comparing Pdr1 sequences from fluconazole-suscep-
tible and fluconazole-resistant cluster P isolates (see also below),
the mutation responsible for resistance was deduced to be
Asn283Ile in the KM1 isolates, Gly348Asp in the KM2 isolate,
Trp780Gly in the KM4 isolates, and Lys274Glu in the KM5 iso-
lates (or, in isolate KM5-67, a Lys274Glu Ile373Asn double muta-
tion). The fluconazole-resistant KM4 isolates typing to cluster V
had a distinct Pdr1 mutation, Gly558Cys. Thus, transmission pre-
ceded fluconazole resistance, which was selected independently in
each patient. This is consistent, in retrospect, with isolation of
susceptible strains from two different patients (KM1 and KM2).
With respect to the DSY strains from center B, each pair of
fluconazole-susceptible and fluconazole-resistant isolates from 5
different patients shared the same CgMT-J and CgMT-M alleles,
which is consistent with their identification as matched pairs (17).
It is also apparent that 3 of these DSY pairs, along with strain
DSY562 (parent of strain SFY92 analyzed here), are identical to
one another as well, falling within cluster N (Fig. 2 and 3). This
again suggests the possibility of nosocomial transmission followed
by selection for fluconazole resistance. In contrast to the situation
with center A, however, cluster N does not represent a rare allele,
since 8 additional epidemiologically unrelated strains share this
allele. Thus, the relatedness of the center B isolates may reflect a
dominant regional clone rather than nosocomial transmission.
More definitive typing data, perhaps from whole-genome se-
quencing, are required to resolve this.
Although they were collected over a period of 10 months and
are distinguishable by their echinocandin susceptibilities (31), all
7 sequential isolates (LC-A through LC-G) from the center C pa-
tient shared CgMT-J and CgMT-M alleles (Fig. 2 and 3). This
agrees with their previously reported relatedness based on PFGE
and, for the first and final isolates, whole-genome sequence-based
SNP analysis (31). (As is often the case with “whole-genome se-
quences” generated by next-generation sequencing technologies,
many of their tandem repeat regions, including the CgMT-J and
CgMT-M loci, are incomplete.)
PLST for Candida glabrata Epidemiology











FIG 2 DNA parsimony-based dendrogram of CgMT-J sequences from C. glabrata strains derived from center A (KM, red underline), center B (DSY, blue
underline), and center C (LC, green underline); all other strains were derived from diverse, unrelated sources. Also included are corresponding sequences from
NCBI database strains CBS138 and M202019. Brackets indicate clusters with identical or nearly identical sequences, labeled according to the isolate defining that
cluster (e.g., P for BWP). DSY (17) and KM (data not shown) isolates are fluconazole susceptible (no following parentheses) or resistant (following parentheses
indicating the Pdr1 mutation in single letter amino acid code; e.g., K274E indicates a Lys to Glu mutation at Pdr1 residue 274).











FIG 3 DNA parsimony-based dendrogram of CgMT-M sequences (see Fig. 2 legend for details).
PLST for Candida glabrata Epidemiology











Use of surrogate parents for mutational analysis of antifun-
gal resistance. From center A patient KM5, there was one azole-
susceptible isolate (vaginal isolate KM5-46), but CgMT-J and
CgMT-M analyses showed it was unrelated to the 5 resistant KM5
isolates (from mouth, blood, and lung). Sequence analysis of the
Pdr1 gene from each of these resistant KM5 isolates revealed 6
amino acid substitutions relative to Pdr1 from cluster K strain
CBS138, the only strain with a completed genome. To deduce
which if any of these might be responsible for resistance, the resis-
tant KM5 Pdr1 sequence was compared to the Pdr1 sequences of
susceptible isolates from patients KM1 and KM2, which were sim-
ilarly typed by CgMT-J and CgMT-M to cluster P (Fig. 2 and 3).
These surrogate parents shared all but one of the substitutions,
specifically, Lys274Glu. In support of its role in resistance, the
Lys274Glu substitution is within a Pdr1 region in which multiple
other resistance-conferring mutations have been mapped (17),
while the 5 other substitutions (between residues Ser76 and
Thr143) are upstream of any known resistance-conferring muta-
tion.
C. glabrata clinical isolate 34-028-512 (cluster S) is fluconazole
resistant and exhibits CDR1 upregulation (15). As is typical of
other resistant strains (16, 17), resistance in 34-028-512 was re-
versed in a Pdr1 gene disruptant; however, sequence analysis re-
vealed wild-type Pdr1, and resistance was also reversed by disrup-
tion of the gene encoding mitogen-activated protein (MAP)
kinase Slt2 (data not shown). The latter effect, which is not ob-
served in strains with Pdr1 mutations, suggests that resistance in
34-028-512 is conferred by a mutation activating Slt2, which then
activates Pdr1. Sequencing showed that Slt2 itself was wild type,
but the substitution Gly567Ala (relative to CBS138) was identified
in protein phosphatase Ptp2 (CAGL0L02827g) that, in Saccharo-
myces cerevisiae, regulates Slt2 activity. As in CBS138, BLAST anal-
ysis showed that the equivalent residue is Gly in all four C.
glabrata-related species with partially sequenced genomes (e.g.,
Candida bracarensis andNakaseomyces delphensis); thus, it seemed
likely that 34-028-512 had mutated Ptp2. Since its parent strain
was not available, the Ptp2 gene was sequenced from cluster S
surrogate parents CE-03, CE-18, and BWS (all of which are flu-
conazole susceptible). Ala567 was common to all, which we con-
sequently conclude is a polymorphism rather than a resistance-
conferring mutation.
As a final example of how typing can provide surrogate parents
for mutational analysis of antifungal resistance, we recently de-
scribed three C. glabrata clinical strains that exhibit caspofungin
reduced susceptibility but micafungin increased susceptibility
(CRS-MIS), and we subsequently identified substitutions (again
relative to CBS138) in their sphingolipid biosynthesis genes (42).
For two of these, complementation experiments confirmed that
their Fen1 substitutions were mutations responsible for their
CRS-MIS phenotype. For the third, strain 4743, tentative support
for the role of an Ile339Met substitution in Ifa38 was obtained by
sequencing its gene from 7 diverse C. glabrata strains, all of which
encoded Ile339 as in CBS138 (42). However, in retrospect, none of
the sequenced strains were from cluster V, which includes 4743
(Fig. 2 and 3), and so here we sequenced the Ifa38 gene from
surrogate parent strains BWV, BXC, and DPL23 (none of which
exhibit the CRS-MIS phenotype). All three encode Met339, and
thus this substitution represents a polymorphism rather than a
CRS-MIS-conferring mutation.
Conclusions. Health care-associated infections may be endog-
enous in origin or nosocomially transmitted, and the only way to
distinguish between these two is through strain typing. Currently,
however, strain typing is rarely pursued by clinical laboratories, at
least in part due to the technical complexities and costs associated
with established methods, including MLST, PFGE, and MLVA, or
emerging methods such as whole-genome sequencing. These is-
sues were directly addressed here, with respect to the opportunis-
tic yeast C. glabrata, by using sequence-based typing services that
target the polymorphic, tandem-repeat-containing loci CgMT-J
and CgMT-M. The PLST protocol was robust, yielding high-qual-
ity sequencing chromatograms for nearly all of the200 amplifi-
cations analyzed here. Furthermore, samples required minimal
preparation— glass bead disruption followed by heating to 100°C
sufficed—and were subsequently shipped without biohazard
packaging, facilitating the commercial outsourcing of the ampli-
fication and sequencing steps. CgMT-J and CgMT-M yielded
largely congruent results despite representing distinct chromo-
somes and coding versus noncoding loci. This congruence indi-
cates that these single loci provide reliable phylogenetic informa-
tion, and it confirms that C. glabrata is a predominantly clonal
species in which sexual reproduction and horizontal gene transfer
have contributed minimally to its evolution (30, 33, 43). On the
other hand, this clonality means that strain resolution can be lim-
iting; this is illustrated by large clusters such as N that include
geographically diverse isolates (3 countries and at least 5 U.S.
states). Additional typing loci that resolve these clusters are cur-
rently being sought. Nevertheless, CgMT-J and CgMT-M analyses
provided strain resolution that was sufficient to strongly suggest
nosocomial transmission of C. glabrata between patients at one
center and its possible role at another. Extension of PLST to other
health care-associated pathogens warrants investigation.
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